(Q40913176)

24 September 2017

1 reference

title

Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia (English)

1 reference

24 September 2017

0 references

Pneumocystis carinii

1 reference

1 reference

H F Vöhringer

1

1 reference

24 September 2017

K Arastéh

series ordinal

2

1 reference

24 September 2017

publication date

1 May 1993

1 reference

Clinical Pharmacokinetics

24 September 2017

published in

1 reference

24 September 2017

volume

24

1 reference

24 September 2017

issue

5

1 reference

24 September 2017

page(s)

388-412

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199324050-00004

24 September 2017

exact match

0 references

cites work

Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Pharmacokinetic comparison of three clindamycin phosphate dosing schedules

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial.

1 reference

12 December 2020

Pharmacokinetics of intravenous pentamidine in patients with normal renal function or receiving hemodialysis

1 reference

12 December 2020

Distribution of primaquine in human blood: drug-binding to alpha 1-glycoprotein

1 reference

12 December 2020

Trimethoprim-Sulfamethoxazole Treatment ofPneumocystis cariniiPneumonia in Adults

1 reference

12 December 2020

Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features

1 reference

12 December 2020

Factors determining pulmonary deposition of aerosolized pentamidine in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Inhaled or intravenous pentamidine therapy for Pneumocystis carinii pneumonia in AIDS. A randomized trial.

1 reference

12 December 2020

Effect of azotemia in dogs on the pharmacokinetics of pentamidine

1 reference

12 December 2020

Pentamidine Isethionate in the Treatment of Pneumocystis carinii Pneumonia

1 reference

12 December 2020

Diabetes mellitus following pentamidine-induced hypoglycemia in humans

1 reference

12 December 2020

Multiple-dose pharmacokinetics and in vitro antimalarial activity of dapsone plus pyrimethamine (Maloprim) in man.

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia

1 reference

12 December 2020

Hydroxylation of pentamidine by rat liver microsomes

1 reference

12 December 2020

Pentamidine and renal toxicity

1 reference

12 December 2020

Update on pentamidine for the treatment of Pneumocystis carinii pneumonia.

1 reference

12 December 2020

Higher pentamidine levels in AIDS patients with hypoglycemia and azotemia during treatment of Pneumocystis carinii pneumonia

1 reference

12 December 2020

Treatment of experimental Pneumocystis carinii pneumonia with analogs of pentamidine

1 reference

12 December 2020

Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugs

1 reference

12 December 2020

Trimetrexate-leucovorin dosage evaluation study for treatment of Pneumocystis carinii pneumonia

1 reference

12 December 2020

Clinical Pharmacology of Intravenously Administered Trimethoprim-Sulfamethoxazole

1 reference

12 December 2020

Clindamycin in the treatment of obstetric and gynecologic infections: a review.

1 reference

12 December 2020

Comparison of pentamidine isethionate andtrimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia

1 reference

12 December 2020

Eflornithine versus cotrimoxazole in the treatment of Pneumocystis carinii pneumonia in AIDS patients

1 reference

12 December 2020

Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies

1 reference

12 December 2020

Clindamycin/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS

1 reference

12 December 2020

Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole)

1 reference

12 December 2020

Pneumocystis carinii pneumonitis in children with malignancies

1 reference

12 December 2020

Pentamidine: a review

1 reference

12 December 2020

Risk factors for hypoglycemia associated with pentamidine therapy for Pneumocystis pneumonia

1 reference

12 December 2020

Pharmacokinetic evaluation of two dosage regimens of clindamycin phosphate

1 reference

12 December 2020

Distribution of pentamidine in patients with AIDS

1 reference

12 December 2020

Primary and secondary metabolism of pentamidine by rats

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole in the treatment of adults with pneumonia due to Pneumocystis carinii

1 reference

12 December 2020

Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial

1 reference

12 December 2020

Comparative bacteriological investigations with the combination trimethoprim/sulfamethoxazole in vitro and in vivo

1 reference

12 December 2020

Are corticosteroids beneficial as adjunctive therapy for Pneumocystis pneumonia in AIDS?

1 reference

12 December 2020

Clindamycin/primaquine for treatment of Pneumocystis carinii pneumonia in AIDS.

1 reference

12 December 2020

Pneumocystis carinii pneumonia in Stockholm, Sweden: treatment, outcome, one-year-follow-up and pyrimethamine prophylaxis

1 reference

12 December 2020

Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole

1 reference

12 December 2020

Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men.

1 reference

12 December 2020

The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia

1 reference

12 December 2020

Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fill

1 reference

12 December 2020

Interaction between aromatic diamidines and nucleic acids: possible implications for chemotherapy

1 reference

12 December 2020

Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agent

1 reference

12 December 2020

Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis

1 reference

12 December 2020

Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo

1 reference

12 December 2020

Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Characterization of de novo folate synthesis in Pneumocystis carinii and Toxoplasma gondii: potential for screening therapeutic agents

1 reference

12 December 2020

Phase I studies with trimetrexate: clinical pharmacology, analytical methodology, and pharmacokinetics

1 reference

12 December 2020

Effects of trypanocides on the fine structure of target organisms

1 reference

12 December 2020

Treatment of Pneumocystis carinii pneumonitis. A comparative trial of sulfamethoxazole-trimethoprim v pentamidine in pediatric patients with cancer: report from the Children's Cancer Study Group

1 reference

12 December 2020

Dapsone in low doses prevents Pneumocystis carinii pneumonia in the rat model

1 reference

12 December 2020

A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Experimental studies on the nephrotoxicity of pentamidine in rats

1 reference

12 December 2020

Selective delivery of pentamidine to the lung by aerosol.

1 reference

12 December 2020

Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis

1 reference

12 December 2020

Treatment of malaria--1990.

1 reference

12 December 2020

Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients

1 reference

12 December 2020

Clinical pharmacokinetics of co-trimazine

1 reference

12 December 2020

Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

[A new method of treating interstitial plasma cell pneumonia in premature infant with 5-valent antimony & aromatic diamidines]

1 reference

12 December 2020

Eflornithine for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: a preliminary review

1 reference

12 December 2020

Serum trimethoprim and sulphamethoxazole levels in AIDS.

1 reference

12 December 2020

Drug therapy reviews: trimethoprim-sulfamethoxazole

1 reference

12 December 2020

Studies on the pharmacokinetics of primaquine

1 reference

12 December 2020

Development of pentamidine analogues as new agents for the treatment of Pneumocystis carinii pneumonia

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial

1 reference

12 December 2020

Can the course of high dose cotrimoxazole for Pneumocystis carinii pneumonia in AIDS be shorter? A possible solution to the problem of cotrimoxazole toxicity

1 reference

12 December 2020

Assessment of therapy for pneumocystis carinii pneumonia. PCP Therapy Project Group

1 reference

12 December 2020

A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group

1 reference

12 December 2020

The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.

1 reference

12 December 2020

Failure of pentamidine isethionate to provide chemoprophylaxis against Pneumocytis carinii infection in rats

1 reference

12 December 2020

[Pneumocystis carinii pneumonia in HIV infection. Diagnosis, prognostic factors and curative treatment]

1 reference

12 December 2020

The pharmacology, mode of action and therapeutic potentialities of stilbamidine, pentamidine, propamidine and other aromatic diamidines a review

1 reference

12 December 2020

Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Chemotherapeutic implications of polyamine biosynthesis inhibition

1 reference

12 December 2020

Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite

1 reference

12 December 2020

Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia

1 reference

12 December 2020

The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency

1 reference

12 December 2020

Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia

1 reference

12 December 2020

Clinical pharmacology of trimetrexate

1 reference

12 December 2020

Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia

1 reference

12 December 2020

Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro

1 reference

12 December 2020

Efficacy of clindamycin/primaquine versus trimethoprim/sulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia

1 reference

12 December 2020

Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop

1 reference

12 December 2020

High-performance liquid chromatographic method for measurement of pentamidine in plasma and its application in an immunosuppressed patient with renal dysfunction

1 reference

12 December 2020

Pneumocystis carinii pneumonia: therapy and prophylaxis

1 reference

12 December 2020

Determinants of serum pentamidine concentration in the human

1 reference

12 December 2020

Treatment of Pneumocystis carinii pneumonia in patients with AIDS.

1 reference

12 December 2020

Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone

1 reference

12 December 2020

Pentamidine therapy in renal failure: case report and literature review.

1 reference

12 December 2020

Dapsone in saliva and plasma of man

1 reference

12 December 2020

1 reference

12 December 2020

Persistence of Pneumocystis carinii in lung tissue of acquired immunodeficiency syndrome patients treated for pneumocystis pneumonia

1 reference

12 December 2020

New developments in the treatment of Pneumocystis carinii pneumonia

1 reference

12 December 2020

Pneumocystis carinii pneumonia treated with eflornithine in AIDS patients resistant to conventional therapy.

1 reference

12 December 2020

Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia.

1 reference

12 December 2020

[FURTHER EXPERIENCES IN THE TREATMENT OF INTERSTITIAL PLASMA CELL PNEUMONIA WITH PENTAMIDIN]

1 reference

12 December 2020

Clindamycin and primaquine as primary treatment for mild and moderately severePneumocystis carinii pneumonia in patients with AIDS

1 reference

12 December 2020

Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia

1 reference

12 December 2020

Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity

1 reference

12 December 2020

A new drug (566C80) for the treatment of Pneumocystis carinii pneumonia

1 reference

12 December 2020

Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function

1 reference

12 December 2020

Selective enhancement of pentamidine uptake in the lung by aerosolization and delivery in liposomes

1 reference

12 December 2020

Aerosolized pentamidine for Pneumocystis carinii pneumonia

1 reference

12 December 2020

Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial

1 reference

12 December 2020

The contribution of N-hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects

1 reference

12 December 2020

Pharmacokinetics of primaquine in man. II. Comparison of acute vs chronic dosage in Thai subjects

1 reference

12 December 2020

Pentamidine pharmacokinetics in patients with AIDS with impaired renal function.

1 reference

12 December 2020

Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions

1 reference

12 December 2020

Pharmacokinetic justification of antiprotozoal therapy. A US perspective

1 reference

12 December 2020

The Combination Trimethoprim-Sulphamethoxazole

1 reference

12 December 2020

1 reference

12 December 2020

Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis

1 reference

12 December 2020

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study

1 reference

12 December 2020

10.2165/00003088-199324050-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

1052561005

0 references

1 reference